Read + Share
Mak DY, Tjong MC, Louie AV. Usage of Radiotherapy With Osimertinib Plus Bevacizumab Versus Osimertinib for
Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations. J Thorac Oncol 2023;18:e3-e4.
PMID: 36543437
|
 |
|
Mak DY, Tjong MC, Louie AV. Usage of Radiotherapy With Osimertinib Plus Bevacizumab Versus Osimertinib for
Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations. J Thorac Oncol 2023;18:e3-e4.
PMID: 36543437
|
|
|
|